AMS — Advanced Medical Solutions Cashflow Statement
0.000.00%
- £385.13m
- £455.39m
- £177.52m
- 76
- 23
- 44
- 42
Annual cashflow statement for Advanced Medical Solutions, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 10.7 | 23 | 24.9 | 18.9 | 11.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.61 | 1.98 | 2.44 | 2.92 | 3.09 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.34 | -2.8 | -9.3 | -20.2 | -11.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 21.5 | 31 | 26.9 | 12.3 | 19.5 |
Capital Expenditures | -5.26 | -6.46 | -9.96 | -9.85 | -8.74 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -21.5 | 0.137 | -1.92 | -10.4 | -58.4 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -26.8 | -6.33 | -11.9 | -20.3 | -67.1 |
Financing Cash Flow Items | -0.735 | -0.7 | -0.617 | -0.362 | -3.99 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.82 | -5.11 | -6.32 | -13.6 | 5.48 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.9 | 19.1 | 9.3 | -22.1 | -43.1 |